Literature DB >> 19210230

gamma-Herpesvirus-induced protection against bacterial infection is transient.

Eric J Yager1, Frank M Szaba, Larry W Kummer, Kathleen G Lanzer, Claire E Burkum, Stephen T Smiley, Marcia A Blackman.   

Abstract

Herpesviruses are widely disseminated in the population and establish lifelong latency, which is associated with a variety of pathological consequences. A recent report showed that mice latently infected with either murine gamma-herpesvirus-68 (gammaHV68) or murine cytomegalovirus (mCMV), mouse pathogens genetically similar to the human herpesviruses, Epstein-Barr virus, Kaposi's sarcoma-associated herpesvirus, and cytomegalovirus, had enhanced resistance to subsequent bacterial infection, suggesting protective as well as deleterious effects of latency. Here we confirm that latent gammaHV68 infection confers protection against subsequent infection with Listeria monocytogenes. However, the effect is transient, lasting only a few months.

Entities:  

Mesh:

Year:  2009        PMID: 19210230      PMCID: PMC2952138          DOI: 10.1089/vim.2008.0086

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  24 in total

1.  Latent antigen vaccination in a model gammaherpesvirus infection.

Authors:  E J Usherwood; K A Ward; M A Blackman; J P Stewart; D L Woodland
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

Review 2.  Epstein-Barr virus: the first human tumor virus and its role in cancer.

Authors:  J S Pagano
Journal:  Proc Assoc Am Physicians       Date:  1999 Nov-Dec

Review 3.  Natural history of murine gamma-herpesvirus infection.

Authors:  A A Nash; B M Dutia; J P Stewart; A J Davison
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-04-29       Impact factor: 6.237

Review 4.  Dissecting the host response to a gamma-herpesvirus.

Authors:  P C Doherty; J P Christensen; G T Belz; P G Stevenson; M Y Sangster
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-04-29       Impact factor: 6.237

Review 5.  Epidemiologic aspects of Epstein-Barr virus (EBV)-associated diseases.

Authors:  W Henle; G Henle
Journal:  Ann N Y Acad Sci       Date:  1980       Impact factor: 5.691

6.  An epidemiologic and clinical study of nasopharyngeal carcinoma.

Authors:  J H Ho
Journal:  Int J Radiat Oncol Biol Phys       Date:  1978 Mar-Apr       Impact factor: 7.038

7.  Pathological changes in the spleens of gamma interferon receptor-deficient mice infected with murine gammaherpesvirus: a role for CD8 T cells.

Authors:  B M Dutia; C J Clarke; D J Allen; A A Nash
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

8.  Gamma interferon is not essential for recovery from acute infection with murine gammaherpesvirus 68.

Authors:  S R Sarawar; R D Cardin; J W Brooks; M Mehrpooya; A M Hamilton-Easton; X Y Mo; P C Doherty
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

9.  Immune control of the number and reactivation phenotype of cells latently infected with a gammaherpesvirus.

Authors:  Scott A Tibbetts; Linda F van Dyk; Samuel H Speck; Herbert W Virgin
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

10.  The influence of immunologically committed lymphoid cells on macrophage activity in vivo.

Authors:  G B Mackaness
Journal:  J Exp Med       Date:  1969-05-01       Impact factor: 14.307

View more
  38 in total

Review 1.  Immune modulation during latent herpesvirus infection.

Authors:  Douglas W White; R Suzanne Beard; Erik S Barton
Journal:  Immunol Rev       Date:  2012-01       Impact factor: 12.988

2.  Sleep and fatigue in mice infected with murine gammaherpesvirus 68.

Authors:  Melissa D Olivadoti; Jason B Weinberg; Linda A Toth; Mark R Opp
Journal:  Brain Behav Immun       Date:  2011-01-24       Impact factor: 7.217

Review 3.  Infectious Mononucleosis.

Authors:  Samantha K Dunmire; Kristin A Hogquist; Henry H Balfour
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

4.  Cytomegalovirus infection enhances the immune response to influenza.

Authors:  David Furman; Vladimir Jojic; Shalini Sharma; Shai S Shen-Orr; Cesar J L Angel; Suna Onengut-Gumuscu; Brian A Kidd; Holden T Maecker; Patrick Concannon; Cornelia L Dekker; Paul G Thomas; Mark M Davis
Journal:  Sci Transl Med       Date:  2015-04-01       Impact factor: 17.956

5.  Evaluation of non-reciprocal heterologous immunity between unrelated viruses.

Authors:  Jenny W Che; Liisa K Selin; Raymond M Welsh
Journal:  Virology       Date:  2015-03-31       Impact factor: 3.616

6.  Herpesvirus latency and symbiotic protection from bacterial infection.

Authors:  Erik S Barton; Douglas W White; Herbert W Virgin
Journal:  Viral Immunol       Date:  2009-02       Impact factor: 2.257

Review 7.  Microbiome and malignancy.

Authors:  Claudia S Plottel; Martin J Blaser
Journal:  Cell Host Microbe       Date:  2011-10-20       Impact factor: 21.023

Review 8.  Coinfections: Another Variable in the Herpesvirus Latency-Reactivation Dynamic.

Authors:  Tiffany A Reese
Journal:  J Virol       Date:  2016-05-27       Impact factor: 5.103

9.  γ-herpesvirus latency attenuates Mycobacterium tuberculosis infection in mice.

Authors:  Halli E Miller; Kaitlin E Johnson; Vera L Tarakanova; Richard T Robinson
Journal:  Tuberculosis (Edinb)       Date:  2019-04-30       Impact factor: 3.131

10.  Gammaherpesvirus latency induces antibody-associated thrombocytopenia in mice.

Authors:  Michael L Freeman; Claire E Burkum; Kathleen G Lanzer; Alan D Roberts; Mykola Pinkevych; Asako Itakura; Lawrence W Kummer; Frank M Szaba; Miles P Davenport; Owen J T McCarty; David L Woodland; Stephen T Smiley; Marcia A Blackman
Journal:  J Autoimmun       Date:  2012-12-14       Impact factor: 7.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.